Brief: Vectus Biosystems Signed A Binding Term Sheet With Xortx Therapeutics Inc
17/10/2025 08:39
Oct 17 (Reuters) - Vectus Biosystems Ltd VBS.AX: SIGNED A BINDING TERM SHEET WITH XORTX THERAPEUTICS INC SALE OF CO'S VB4-P5 RENAL SMALL MOLECULE COMPOUND FOR $3 MILLION Further company coverage: VBS.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on XORTX Therapeutics
See all newsBrief: Xortx Outlines Anticipated Health Canada Clinical Trial Application For Xrx-026 For Gout
Brief: XORTX Therapeutics Announces Initiation Of Drug And Tablet Manufacturing For XRx-026 Program
Brief: Xortx Announces Termination And Postponement Of Investor Relations Program
Brief: XORTX Announces Director Resignation
Brief: Xortx Announces Us$5 Million Public Offering